Published in Clin Ophthalmol on June 01, 2008
Editorial foreword. Clin Ophthalmol (2008) 0.75
Evidence based medicine: what it is and what it isn't. BMJ (1996) 66.70
Ranibizumab for neovascular age-related macular degeneration. N Engl J Med (2006) 30.63
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol (2001) 21.37
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol (2002) 16.89
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med (2005) 15.46
Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol (2002) 14.17
Pegaptanib for neovascular age-related macular degeneration. N Engl J Med (2004) 12.01
Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA (2003) 8.21
Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol (1998) 7.34
Failing the public health--rofecoxib, Merck, and the FDA. N Engl J Med (2004) 7.06
Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology (2001) 6.82
Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology (1991) 5.91
Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med (1985) 5.53
Bias and causal associations in observational research. Lancet (2002) 5.36
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med (1992) 4.90
Using numerical results from systematic reviews in clinical practice. Ann Intern Med (1997) 4.38
A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med (2007) 4.12
Randomized controlled trials: do they have external validity for patients with multiple comorbidities? Ann Fam Med (2006) 3.55
Topical antibiotics for acute bacterial conjunctivitis: a systematic review. Br J Gen Pract (2001) 3.46
Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol (1991) 3.30
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology (2005) 3.20
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1. Ophthalmology (2001) 3.12
Using clinical evidence. BMJ (2001) 2.97
Results of the European Glaucoma Prevention Study. Ophthalmology (2005) 2.91
Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology (2000) 2.74
Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology (2007) 2.38
Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1. Am J Ophthalmol (2003) 2.06
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. Arch Ophthalmol (2006) 2.04
The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results. Ophthalmology (2004) 2.01
Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol (2005) 1.82
Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. Ophthalmology (2007) 1.72
Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema. Arch Ophthalmol (2005) 1.66
Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch Ophthalmol (1990) 1.51
Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology (2004) 1.50
Sample size for a clinical trial: why do some trials need only 100 patients and others 1000 patients or more? Ophthalmology (2006) 1.46
Golden Jubilee Lecture. Randomised clinical trials of choroidal melanoma treatment. Indian J Ophthalmol (2003) 1.43
All members of primary care team are aware of importance of evidence based medicine. BMJ (1998) 1.38
Bibliometric analysis of the literature of randomized controlled trials. J Med Libr Assoc (2005) 1.31
An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data. Ophthalmology (2005) 1.31
Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study. Ophthalmology (2007) 1.25
Pattern visual evoked potentials in the assessment of visual acuity in malingering. Ophthalmology (2007) 1.20
The "not quite" natural history of normal-tension glaucoma. Ophthalmology (2001) 1.09
Quiet in the library. N Engl J Med (2005) 1.06
Epidemiology and management of orbital fractures. Curr Opin Ophthalmol (2004) 1.01
Noninvitation of eligible individuals to participate in pediatric studies: a qualitative study. Arch Pediatr Adolesc Med (2007) 1.00
Precision of conjunctival provocation tests in right and left eyes. J Allergy Clin Immunol (1993) 0.99
How evidence-based are publications in clinical ophthalmic journals? Invest Ophthalmol Vis Sci (2006) 0.98
The impact of the optic neuritis treatment trial on the practices of ophthalmologists and neurologists. Ophthalmology (1999) 0.95
Engaging families in health services research on childhood visual impairment: barriers to, and degree and nature of bias in, participation. Br J Ophthalmol (2004) 0.90
Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity. Am J Ophthalmol (1998) 0.90
New treatments for AMD. Ophthalmology (2006) 0.90
Do skin prick and conjunctival provocation tests predict symptom severity in seasonal allergic rhinoconjunctivitis? Clin Exp Allergy (2006) 0.86
Interpreting automated perimetry. Indian J Ophthalmol (2001) 0.86
Anecortave acetate for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Eur J Ophthalmol (2005) 0.85
Pharmaceutical companies and ophthalmic research. Ophthalmology (2005) 0.83
Heparin use in acute ischaemic stroke: does evidence change practice? QJM (2005) 0.81
Eye disorders: bacterial conjunctivitis. West J Med (2000) 0.77
Clinical trial design issues: at least 10 things you should look for in clinical trials. J Clin Pharmacol (2006) 0.77
Cure for dry eye. Ophthalmology (2007) 0.76
Influence of prior assignment on refusal rates in a trial of supplemental oxygen for retinopathy of prematurity. Paediatr Perinat Epidemiol (2006) 0.76
The pursuit of excellence. Minn Med (2006) 0.76
Objective measurement of allergic reactions in the eye. Curr Opin Allergy Clin Immunol (2004) 0.76
Sources of evidence in HIV/AIDS care: pilot study comparing family physicians and AIDS service organization staff. BMC Health Serv Res (2004) 0.76
Prophylactic treatment of Wilson's disease. N Engl J Med (1968) 0.76